Overview
Transforming challenges into success stories for companies worldwide.
Our approach is anchored in advanced technology, enriched by cultural insights and guided by three core principles - Seamless Integration, Convenient Management and Dynamic Course-correction. By embracing these values, we ensure that every project is executed with meticulous care, precision and forward-thinking.
Our Expertise
Precision-driven solutions for modern pharmaceuticals
Biotechnology
Pharma Access provides biotechnology facility design, engineering and turnkey project delivery, backed by over 25 years of pharmaceutical engineering experience. We develop manufacturing facilities for biologics, vaccines and advanced therapies, translating process requirements into coordinated facility layouts and engineering systems.
From bioprocessing to fill-finish, our scope integrates cleanrooms, HVAC, clean utilities, automation and process equipment interfaces. We support projects from concept through commissioning, qualification and validation (CQV), with designs aligned to applicable GMP requirements and project-specific production needs.
We specialize in:
- Process-driven facility layouts for bioprocessing and fill-finish.
- Single-use bioprocess equipment integration.
- Cleanroom, HVAC and clean utility engineering.
- Material and personnel flow planning with product-specific segregation.
- Process automation and environmental monitoring system integration.
- CQV planning, execution and technical documentation.
Products
- Monoclonal Antibodies (mAbs)
- Antibody–Drug Conjugates (ADCs)
- Cell and Gene Therapies (CGT)
- Vaccines
- Plasma-Derived Products
- Insulin
- Peptides
Sterile Manufacturing
Pharma Access provides sterile manufacturing facility design, engineering and turnkey project delivery for aseptic and terminally sterilized products. Our approach integrates cleanrooms, HVAC, clean utilities, process equipment and contamination-control requirements to support safe, efficient and compliant manufacturing environments.
From concept through CQV, we engineer sterile facilities around product requirements, processing strategy and applicable GMP expectations.
We focus on several key aspects to guarantee product integrity and compliance, including:
- Aseptic and terminal sterilization facility design
- Cleanroom, HVAC and pressure cascade engineering
- Isolator, RABS and sterile filling line integration
- Clean utility and sterilization system engineering
- Contamination control, monitoring and CQV support
With a focus on quality and customer satisfaction, we at Pharma Access are dedicated to providing effective sterile manufacturing solutions that meet the needs of the pharmaceutical industry.
Products
- Injectables
- Small Volume Parenterals (SVP)
- Large Volume Parenterals (LVP)
- Lyophilized Products
- Container Formats
- Vials
- Ampoules
- Pre-filled Syringes
- Cartridges
- Other Sterile Applications
- Ophthalmic Products
- Selected Nasal Products
- Otic Products
- Selected Inhalation Products
- Sterile Implants
Oral Solid Dosage
Pharma Access provides oral solid dosage facility design, engineering and turnkey project delivery for tablet, capsule and other solid-dose manufacturing facilities.
Our approach integrates process equipment, HVAC, utilities, material and personnel flows, containment requirements and packaging interfaces to support efficient, compliant and scalable OSD manufacturing environments.
- Multiproduct OSD facility design
- Process equipment and utility integration
- Material and personnel flow planning
- Dust control and containment engineering
- Packaging, automation and CQV support
Products
- Tablets
- Conventional Tablets
- Caplets
- Chewable Tablets
- Effervescent Tablets
- Orally Disintegrating Tablets
- Sublingual Tablets
- Buccal Tablets
- Delayed-Release Tablets
- Extended-Release Tablets
- Capsules
- Hard Capsules
- Softgel Capsules
- Other Solid Forms
- Lozenges
- Powders & Granules
- Powder Sachets / Stick Packs
Oral Liquid Dosage
Pharma Access provides oral liquid manufacturing facility design, engineering and turnkey project delivery for syrups, solutions, suspensions, emulsions and other liquid dosage forms.
Our approach integrates process equipment, sanitary piping, utilities, automation, filling and packaging systems to support efficient, hygienic and compliant manufacturing environments.
- Liquid processing and mixing system design
- Sanitary piping and product transfer systems
- CIP and cleaning system integration
- Filling, packaging and automation integration
- Utility engineering and CQV support
Products
- Syrups
- Oral Solutions
- Suspensions
- Emulsions
- Oral Drops
- Tinctures
- Other Oral Liquid Preparations
bangalore aragen biologics
Production Capacity (per annum)
- 15 million doses of mAbs
- Drug substance manufacturing facility
- 2x2KL single-use bioreactors
14,000 m2
Built-up area
23,000 m2
Ducting
8,500 m2
MCR
60,000 mtrs
Cables
Confidential UAE
Production Capacity (per annum)
- 30 million doses of mAbs
- 2 suites for 2x2KL single-use bioreactors
26,000 m2
Built-up area
33,500 m2
Ducting
28,000 m2
MCR
1,50,000 mtrs
Cables
Algeria Inphamedis
Production Capacity (per annum)
- LVP: 12 million units
- Ophthalmic: 6 million units
- Ampoule / Vial: 10 million units
12,000 m2
Built-up area
18,000 m2
Ducting
11,500 m2
MCR
70,000 mtrs
Cables
Saudi Arabia SPPF
Production Capacity (per annum)
- Sterile: 3 million units of 100 ml Fill volume
- OLD: 1.2 million units
- Vial: 2 million units
- Powder: 1 million units
- OSD: 60 million doses
10,000 m2
Built-up area
10,000 m2
Ducting
8,500 m2
MCR
40,000 mtrs
Cables
Algeria Sophal
Production Capacity (per annum)
- Dry Injection (Cephalosporin): 13 million units
3,500 m2
Built-up area
4,500 m2
Ducting
2,500 m2
MCR
NA
Cables
Algeria Biothera
Production Capacity (per annum)
- 3 million units
- 4 million units
- Ampoule & Vial: 15 million units
6,200 m2
Built-up area
12,000 m2
Ducting
5,200 m2
MCR
47,000 mtrs
Cables
Kuwait Al Shifa
Production Capacity (per annum)
- Vials: 8 million units
- Ampoule: 18 million units
- Ophthalmic: 62 million units
22,000 m2
Built-up area
21,000 m2
Ducting
12,000 m2
MCR
72,500 mtrs
Cables
Oman Izz Pharma, Nizwa
Production Capacity (per annum)
- Sterile: 30 million doses
20,000 m2
Built-up area
7,600 m2
Ducting
5,500 m2
MCR
60,000 mtrs
Cables
Oman Menagen
Production Capacity (per annum)
- OSD: 65 million units
8,500 m2
Built-up area
8,000 m2
Ducting
5,500 m2
MCR
35,000 mtrs
Cables
Jordan Pharmatek
Production Capacity (per annum)
- OSD Tablets: 150 million units Capsules: 60 million units
- OLD: 8 million units
- Liquid Sachets: 30 million units
- R&D Facility: OSD & Semi-solid OSD: 21 million units
9,000 m2
Built-up area
16,000 m2
Ducting
10,000 m2
MCR
84,000 mtrs
Cables
Algeria Merinal Laboratories
Production Capacity (per annum)
- OSD: Tablets: 300 million units Capsules: 800 million units
- Softgel: 300 million units Powder Sticks: 150 million units
- OLD: 20 million units
- Ointment: 10 million units
- Softgel Capsule: 35 million
15,000 m2
Built-up area
35,000 m2
Ducting
23,000 m2
MCR
2,70,000 mtrs
Cables
Algeria Saidal, Onco Pharm
Production Capacity (per annum)
- OSD: 24 million units
- Vial: 9 million units
14,000 m2
Built-up area
33,000 m2
Ducting
15,000 m2
MCR
200,000 mtrs
Cables
Algeria SARL Alfacare
Production Capacity (per annum)
- Oncological OSD Line: 30 million doses
- Oncological Injectable Line (Vial and Lyophilized Vials): 6 million units
9,800 m2
Built-up area
10,000 m2
Ducting
7,200 m2
MCR
96,500 mtrs
Cables
Iraq Al Wafi
Production Capacity (per annum)
- 300 million tablets a year
- 35 million ampoules a year
7,850 m2
Built-up area
9,000 m2
Ducting
7,900 m2
MCR
96,000 mtrs
Cables
Algeria Onyx Pharmaceutique
Production Capacity (per annum)
- OSD Tablets: 280 million units Capsules: 60 million units
- Ointment: 3 million units
6,500 m2
Built-up area
12,000 m2
Ducting
6,200 m2
MCR
60,500 mtrs
Cables
Algeria Janismed
Production Capacity (per annum)
- OSD Tablets: 170 million units Capsules: 20 million units
- OLD: 20 million units
6,200 m2
Built-up area
12,000 m2
Ducting
5,200 m2
MCR
50,500 mtrs
Cables
